EMERALD HEALTH PHARMACEUTICALS INC.

Profile

Company Names

EMERALD HEALTH PHARMACEUTICALS INC.

Addresses

5910 PACIFIC CENTER BLVD, SUITE 320, SAN DIEGO, CA 92121

5910 PACIFIC CENTER BLVD, SUITE 300, SAN DIEGO, CA 92121

5820 NANCY RIDGE DRIVE, ATTENTION: DR. JILL BROADFOOT, SAN DIEGO, CA 92121

Phone Numbers

(858)352-0622
(858) 352-0622
858-361-4499

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$3,301,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-06-23 
$300,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2021-04-12 
$500,000.00 
$500,000.00 
$0.00 
Equity, Debt 
2
2019-06-07 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity, Debt 
1
2017-03-02 
$1,000.00 
$1,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JILL 
 
BROADFOOT 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.   |  EMERALD HEALTH BIOCEUTICALS INC.   |  ACELRX PHARMACEUTICALS INC   |  TALPHERA, INC.
NANCY 
 
COULSON 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.
JAMES 
 
DEMESA 
EXECUTIVE OFFICER, DIRECTOR
ONCOSEC MEDICAL INC   |  EMERALD HEALTH PHARMACEUTICALS INC.
JIM 
 
DEMESA 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.
AVTAR 
 
DHILLON 
EXECUTIVE OFFICER, DIRECTOR
PROTOX THERAPEUTICS INC   |  ONCOSEC MEDICAL INC   |  STEVIA FIRST CORP.   |  ARCH THERAPEUTICS, INC.   |  ARCH THERAPEUTICS, INC.   |  EMERALD HEALTH PHARMACEUTICALS INC.   |  NEMUS BIOSCIENCE, INC.
AVTAR 
S. 
DHILLON 
EXECUTIVE OFFICER, DIRECTOR
EMERALD HEALTH PHARMACEUTICALS INC.
PUNIT 
 
DHILLON 
DIRECTOR
ONCOSEC MEDICAL INC   |  EMERALD HEALTH PHARMACEUTICALS INC.   |  EMERALD HEALTH BIOCEUTICALS INC.   |  NEMUS BIOSCIENCE, INC.   |  ARCH THERAPEUTICS, INC.   |  SKYE BIOSCIENCE, INC.
PUNIT 
S. 
DHILLON 
DIRECTOR
EMERALD HEALTH PHARMACEUTICALS INC.
JAMES 
L. 
HEPELL 
DIRECTOR
EMERALD HEALTH PHARMACEUTICALS INC.
JAMES 
 
HEPPELL 
DIRECTOR
EMERALD HEALTH PHARMACEUTICALS INC.
JAMES 
L. 
HEPPELL 
DIRECTOR
NEMUS BIOSCIENCE, INC.   |  EMERALD HEALTH PHARMACEUTICALS INC.
JIM 
 
HEPPELL 
DIRECTOR
MSI METHYLATION SCIENCES, INC.   |  PROTOX THERAPEUTICS INC   |  MOBIDIA TECHNOLOGY INC.   |  CONTECH ENTERPRISES, INC.   |  EMERALD HEALTH PHARMACEUTICALS INC.   |  EMERALD HEALTH BIOCEUTICALS INC.   |  NEMUS BIOSCIENCE, INC.   |  EMERALD HEALTH SCIENCES INC.
GAETANO 
 
MORELLO 
DIRECTOR
EMERALD HEALTH PHARMACEUTICALS INC.   |  EMERALD HEALTH BIOCEUTICALS INC.   |  EMERALD HEALTH SCIENCES INC.
GAETANO 
A. 
MORELLO 
DIRECTOR
EMERALD HEALTH PHARMACEUTICALS INC.
EDUARDO 
 
MUNOZ 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.
EDUARDO 
S. 
MUNOZ 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.
ALAIN 
 
ROLLAND 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.
LISA 
 
SANFORD 
EXECUTIVE OFFICER
EMERALD HEALTH PHARMACEUTICALS INC.
JOACHIM 
 
SCHUPP 
EXECUTIVE OFFICER
IMPRIMIS PHARMACEUTICALS, INC.   |  EMERALD HEALTH PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-07-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-06-23 
2021-04-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-04-12 
2019-06-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-06-07 
2017-03-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#